Physician profile
Scott Fuerman
NPI 1841315512
$2,432.25
in general payments reported to CMS, 2019-2025
9 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $37.12 · 2021: $258 · 2022: $504 · 2023: $334 · 2024: $124 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,341.44 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $364.85 | 2023-2025 | Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $201.45 | 2020-2022 | |
| Genzyme Corporation | $124.89 | 2023 | |
| Sun Pharmaceutical Industries INC. | $115.91 | 2022 | |
| Mallinckrodt Hospital Products INC. | $95.36 | 2022 | |
| Horizon Therapeutics Plc | $84.83 | 2023 | Tepezza |
| Abbvie INC. | $64.53 | 2022 | |
| Allergan, INC. | $38.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Fuerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.